Medtronic plc (MDTC34) — Cash Flow Reinvestment Rate

Latest as of April 2026: 0.20x

Medtronic plc (MDTC34) has a Cash Flow Reinvestment Rate of 0.20x as of April 2026, reinvesting R$518.00 Million (capex R$488.00 Million plus investments R$-30.00 Million) from operating cash flow of R$2.57 Billion. Check Medtronic plc (MDTC34) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

R$518.00 Million
Capex + Investments

Operating Cash Flow

R$2.57 Billion
BRL

Capital Expenditures

R$488.00 Million
BRL

Medtronic plc Cash Flow Reinvestment Rate (2019–2026)

Historical reinvestment intensity for Medtronic plc across 8 annual periods. Explore Medtronic plc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Medtronic plc (2019–2026)

Year-by-year capital reinvestment analysis for Medtronic plc. For live market cap and broader valuation context, see Medtronic plc market cap and net worth.

Year Reinvestment Rate Total Reinvested (BRL) Operating CF Capex YoY Change
2026 0.34x R$2.52 Billion R$7.33 Billion R$1.90 Billion ▼ -36.1%
2025 0.54x R$3.80 Billion R$7.04 Billion R$1.86 Billion ▼ -7.5%
2024 0.58x R$3.95 Billion R$6.79 Billion R$1.59 Billion ▼ -29.0%
2023 0.82x R$4.95 Billion R$6.04 Billion R$1.46 Billion ▲ +286.6%
2022 0.21x R$1.56 Billion R$7.35 Billion R$1.37 Billion ▼ -27.2%
2021 0.29x R$1.82 Billion R$6.24 Billion R$1.35 Billion ▼ -21.3%
2020 0.37x R$2.68 Billion R$7.23 Billion R$1.21 Billion ▼ -21.0%
2019 0.47x R$3.29 Billion R$7.01 Billion R$1.13 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow